关于药品的环境信息的知识支持:瑞典药物和治疗委员会之间的经验
Elkanah Linder1, Björn Wettermark2, Marie-Louise Ovesjö3,4
1Pharmacoepidemiology & Social Pharmacy, Department of Pharmacy, Uppsala University, Uppsala, Sweden. elkanah.linder@farmaci.uu.se.
BMC health services research
|June 12, 2023
概括
瑞典药物和治疗委员会 (DTCs) 发现环境制药知识支持有价值,但面临数据和透明度挑战. 他们希望有更多的支持和立法来减轻制药产品对环境的影响.
科学领域:
- 环境科学 环境科学
- 药理学 药理学是指药理学的学科.
- 卫生政策 卫生政策
背景情况:
- 瑞典的两个知识支持系统Janusinfo.se和Fass.se提供了关于制药的环境数据.
- 据了解,Janusinfo由公众资助,而Fass则由工业提供.
- 这项研究检查了药物和治疗委员会 (DTC) 与这些系统的经验.
研究的目的:
- 评估DTC使用环境制药数据库的情况.
- 确定需要改进的数据库领域.
- 了解DTC在制药环境影响方面面临的挑战.
主要方法:
- 在2022年3月,一个包含21个问题的横截面调查被电子发送给21个DTC.
- 数据分析涉及描述性统计和诱导性分类.
- 来自18个地区的132名受访者参与了调查,平均响应率为42%.
主要成果:
- DTCs使用知识支持来做出配方决策,并对制药环境方面进行教育.
- Janusinfo更为熟悉,但这两种系统都受到重视;关于Janusinfo的具体建议尤其受到赞赏.
- 主要挑战包括数据缺口,行业透明度问题和实际实施困难. DTC要求对Fass的所有产品提供更多数据,增加知识,提供更明确的指导和支持立法.
结论:
- 环境制药知识支持对瑞典DTC有价值,有助于决策和教育.
- 尽管DTC具有实用性,但与数据可用性,透明度和实际应用相关的重大挑战仍然存在.
- 这些发现为国际配方决策提供了关于药品环境影响的国际决策的见解.
相关概念视频
01:19Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
195
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
195
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:26Drug Administration and Therapy Phases: Overview
562
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
562